% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Trambaiolli:904430,
      author       = {Trambaiolli, Lucas R. and Kohl, Simon H. and Linden, David
                      E. J. and Mehler, David M. A.},
      title        = {{N}eurofeedback training in major depressive disorder: {A}
                      systematic review of clinical efficacy, study quality and
                      reporting practices},
      journal      = {Neuroscience $\&$ biobehavioral reviews},
      volume       = {125},
      issn         = {0149-7634},
      address      = {Amsterdam [u.a.]},
      publisher    = {Elsevier Science},
      reportid     = {FZJ-2021-06000},
      pages        = {33 - 56},
      year         = {2021},
      abstract     = {Major depressive disorder (MDD) is the leading cause of
                      disability worldwide. Neurofeedback training has been
                      suggested as a potential additional treatment option for MDD
                      patients not reaching remission from standard care (i.e.,
                      psychopharmacology and psychotherapy). Here we
                      systematically reviewed neurofeedback studies employing
                      electroencephalography, or functional magnetic
                      resonance-based protocols in depressive patients. Of 585
                      initially screened studies, 24 were included in our final
                      sample (N = 480 patients in experimental and N = 194 in the
                      control groups completing the primary endpoint). We
                      evaluated the clinical efficacy across studies and attempted
                      to group studies according to the control condition
                      categories currently used in the field that affect clinical
                      outcomes in group comparisons. In most studies, MDD patients
                      showed symptom improvement superior to the control group(s).
                      However, most articles did not comply with the most
                      stringent study quality and reporting practices. We conclude
                      with recommendations on best practices for experimental
                      designs and reporting standards for neurofeedback training.},
      cin          = {INM-11},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-11-20170113},
      pnm          = {5252 - Brain Dysfunction and Plasticity (POF4-525)},
      pid          = {G:(DE-HGF)POF4-5252},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:33587957},
      UT           = {WOS:000646741600004},
      doi          = {10.1016/j.neubiorev.2021.02.015},
      url          = {https://juser.fz-juelich.de/record/904430},
}